Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-D]pyrimidin-1-YL]-phenyl}-cyclopropanecarboxamide dimethyl sulfoxide solvate as an MEK1/2 inhibitor

N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-D]pyrimidin-1-YL]-phenyl}-cyclopropanecarboxamide dimethyl sulfoxide solvate as an MEK1/2 inhibitor

US Patent 10738049 · Granted Aug 11, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Noradrenergic and specific serotonergic anxiolytic and antidepressant, method fo2025
IL1-R1 derived inhibitor of IL-1β and use thereof2024
IL1-R1 derived inhibitor of IL-1β and use thereof2024
Substituted 3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]tria2024
Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or b2024
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors2023
Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir 2023
Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathi2022
Human IL1-R1 derived inhibitor of IL-1β2021
Human IL1-R1 derived inhibitor of IL-1β2021
Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or b2021